Long Ideas - On October 3, 2013, PropThink hosted an interview and investor Q&A with Tekmira Pharmaceuticals’ (TKMR) CEO Dr. Mark Murray. A recording and transcript of that … Continue Reading
Read NowLong Ideas - On Tuesday afternoon at 2:30PM ET, Progenics (PGNX) and Salix Pharmaceuticals (SLXP) announced that an FDA advisory committee weighing the Supplemental New Drug Application for … Continue Reading
Read NowLong Ideas - Last week, while most of PropThink’s research team was on vacation, Sunshine Heart (SSH) commenced a secondary offering that should net proceeds of approximately $37 … Continue Reading
Read NowLong Ideas - PropThink has been bullish on Questcor Pharmaceuticals (QCOR) for quite some time, and since our report highlighting the company’s prospects late last year, shares have … Continue Reading
Read NowLong Ideas - Shares of ViroPharma soared by 25% on Friday as Bloomberg reported that the drug developer has hired Goldman Sachs to explore takeover offers following interest … Continue Reading
Read NowLong Ideas - Targeted therapies are the oncologists’ precision tool in treating difficult cancers. Where early therapeutics like radiotherapy and chemotherapy tackle cancers by bombarding all rapidly dividing … Continue Reading
Read NowLong Ideas - The Amarin (AMRN) run-up has been in full swing this month. Recall that in June, Mr. King outlined why he expected a robust run-up into the FDA … Continue Reading
Read Now